JP2023522029A5 - - Google Patents
Info
- Publication number
- JP2023522029A5 JP2023522029A5 JP2022562645A JP2022562645A JP2023522029A5 JP 2023522029 A5 JP2023522029 A5 JP 2023522029A5 JP 2022562645 A JP2022562645 A JP 2022562645A JP 2022562645 A JP2022562645 A JP 2022562645A JP 2023522029 A5 JP2023522029 A5 JP 2023522029A5
- Authority
- JP
- Japan
- Prior art keywords
- igg
- molecule
- modified
- modified igg
- canid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026035921A JP2026097964A (ja) | 2020-04-17 | 2026-03-06 | イヌ科動物抗体バリアント |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063011453P | 2020-04-17 | 2020-04-17 | |
| US63/011,453 | 2020-04-17 | ||
| PCT/US2021/027836 WO2021212081A1 (en) | 2020-04-17 | 2021-04-16 | Canine antibody variants |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026035921A Division JP2026097964A (ja) | 2020-04-17 | 2026-03-06 | イヌ科動物抗体バリアント |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522029A JP2023522029A (ja) | 2023-05-26 |
| JP2023522029A5 true JP2023522029A5 (cg-RX-API-DMAC10.html) | 2024-04-19 |
| JP7879810B2 JP7879810B2 (ja) | 2026-06-24 |
Family
ID=75888187
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562645A Active JP7879810B2 (ja) | 2020-04-17 | 2021-04-16 | イヌ科動物抗体バリアント |
| JP2026035921A Pending JP2026097964A (ja) | 2020-04-17 | 2026-03-06 | イヌ科動物抗体バリアント |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026035921A Pending JP2026097964A (ja) | 2020-04-17 | 2026-03-06 | イヌ科動物抗体バリアント |
Country Status (17)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10093731B2 (en) | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| AU2018318440A1 (en) | 2017-08-15 | 2020-02-13 | Kindred Biosciences, Inc. | IgG Fc variants for veterinary use |
| CN120005022A (zh) | 2019-01-03 | 2025-05-16 | 因外泰克斯公司 | 用于增加治疗剂在犬中的半衰期的组合物及使用方法 |
| JP7671275B2 (ja) | 2019-08-29 | 2025-05-01 | エランコ・ユーエス・インコーポレイテッド | 動物用の抗il31抗体 |
| JP7832123B2 (ja) | 2020-05-11 | 2026-03-17 | インベテックス インコーポレイテッド | 治療薬のイヌにおける半減期を増加させるための組成物及びその使用方法 |
| CN116096741B (zh) | 2020-07-10 | 2024-10-18 | 因外泰克斯公司 | 用于延长治疗剂在猫科动物中的半衰期的组合物和使用方法 |
| CA3194936A1 (en) * | 2020-09-28 | 2022-03-31 | Zoetis Services Llc | Canine antibody variants |
| AU2023289332A1 (en) * | 2022-06-21 | 2024-12-12 | Zoetis Services Llc | Canine antibody mutants |
| US20240254231A1 (en) | 2023-01-20 | 2024-08-01 | PetMedix Ltd. | Therapeutic antibodies |
| WO2025166165A1 (en) * | 2024-02-01 | 2025-08-07 | Zoetis Services, Llc | Compositions and methods for modifying antibody effector functions |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6284471B1 (en) | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
| US5698762A (en) | 1994-12-09 | 1997-12-16 | Dauerman; Leonard | Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons |
| US20030031671A1 (en) | 2001-08-01 | 2003-02-13 | Sydney Welt | Methods of treating colon cancer utilizing tumor-specific antibodies |
| CA2577133A1 (en) | 2004-08-19 | 2006-03-23 | Genentech, Inc. | Polypeptide variants with altered effector function |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
| US9200079B2 (en) | 2004-11-12 | 2015-12-01 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| ES2665954T3 (es) | 2010-08-19 | 2018-04-30 | Zoetis Belgium S.A. | Anticuerpos anti-NGF y su uso |
| JP5833145B2 (ja) * | 2011-02-04 | 2015-12-16 | ゾエティス・エルエルシー | 免疫原性bordetellabronchiseptica組成物 |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| US9617334B2 (en) | 2012-06-06 | 2017-04-11 | Zoetis Services Llc | Caninized anti-NGF antibodies and methods thereof |
| CN114773469B (zh) | 2015-02-05 | 2025-12-19 | 中外制药株式会社 | 包含离子浓度依赖性的抗原结合结构域的抗体,fc区变体,il-8-结合抗体及其应用 |
| PE20181336A1 (es) | 2015-09-18 | 2018-08-21 | Chugai Pharmaceutical Co Ltd | Anticuerpos que se unen a interleucina 8 (il-8) y sus usos |
| US11596699B2 (en) * | 2016-04-29 | 2023-03-07 | CureVac SE | RNA encoding an antibody |
| CN116271014A (zh) * | 2016-08-05 | 2023-06-23 | 中外制药株式会社 | 用于预防或治疗il-8相关疾病的组合物 |
| EP3526246A1 (en) * | 2016-10-17 | 2019-08-21 | Vetoquinol SA | Modified antibody constant region |
| US10093731B2 (en) * | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| EP3866842A4 (en) | 2018-10-18 | 2022-07-13 | Kindred Biosciences, Inc. | FC VARIANTS WITH MODIFIED BINDING TO THE NEONATAL FC RECEPTOR (FCRN) FOR VETERINARY USE |
| CN120005022A (zh) * | 2019-01-03 | 2025-05-16 | 因外泰克斯公司 | 用于增加治疗剂在犬中的半衰期的组合物及使用方法 |
| KR20220066002A (ko) * | 2019-03-20 | 2022-05-23 | 킨드레드 바이오사이언시스, 인코포레이티드 | 의학적 용도의 ngf 길항제 |
| CA3194936A1 (en) * | 2020-09-28 | 2022-03-31 | Zoetis Services Llc | Canine antibody variants |
| MX2023008785A (es) * | 2021-01-28 | 2023-12-14 | Zoetis Services Llc | Mutaciones en regiones constantes de anticuerpos caninos. |
-
2021
- 2021-04-16 IL IL297287A patent/IL297287A/en unknown
- 2021-04-16 JP JP2022562645A patent/JP7879810B2/ja active Active
- 2021-04-16 CN CN202180028973.4A patent/CN115996949A/zh active Pending
- 2021-04-16 CA CA3175921A patent/CA3175921A1/en active Pending
- 2021-04-16 BR BR112022020944A patent/BR112022020944A2/pt unknown
- 2021-04-16 KR KR1020227035765A patent/KR20230005156A/ko active Pending
- 2021-04-16 PE PE2022002420A patent/PE20230108A1/es unknown
- 2021-04-16 EP EP21724863.2A patent/EP4136106A1/en active Pending
- 2021-04-16 WO PCT/US2021/027836 patent/WO2021212081A1/en not_active Ceased
- 2021-04-16 AU AU2021256056A patent/AU2021256056A1/en active Pending
- 2021-04-16 MX MX2022012866A patent/MX2022012866A/es unknown
- 2021-04-16 US US17/918,853 patent/US20230242635A1/en active Pending
- 2021-04-16 PH PH1/2022/552742A patent/PH12022552742A1/en unknown
- 2021-04-19 TW TW110113947A patent/TW202204403A/zh unknown
-
2022
- 2022-10-17 EC ECSENADI202280846A patent/ECSP22080846A/es unknown
- 2022-10-17 CL CL2022002857A patent/CL2022002857A1/es unknown
- 2022-10-18 CO CONC2022/0014695A patent/CO2022014695A2/es unknown
-
2023
- 2023-11-13 CL CL2023003377A patent/CL2023003377A1/es unknown
-
2026
- 2026-03-06 JP JP2026035921A patent/JP2026097964A/ja active Pending
- 2026-03-18 US US19/570,699 patent/US20260193342A1/en active Pending